AnaptysBio, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ANAB Nasdaq 2830 www.anaptysbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AnaptysBio, Inc.

What Makes AnaptysBio (ANAB) an Investment Bet? - Jul 14th, 2026 8:56 am
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - May 21st, 2026 7:40 am
Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High? - May 19th, 2026 7:55 am
How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets - May 15th, 2026 8:18 am
AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - May 14th, 2026 7:55 am
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update - May 12th, 2026 2:15 pm
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus - May 11th, 2026 9:50 am
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors - May 11th, 2026 7:15 am
Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome - May 10th, 2026 7:10 pm
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026? - May 10th, 2026 5:13 pm
Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders - May 8th, 2026 1:45 pm
TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View - May 7th, 2026 10:08 am
Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised - May 7th, 2026 10:04 am
AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy? - May 6th, 2026 10:00 am
Are Medical Stocks Lagging AnaptysBio (ANAB) This Year? - May 5th, 2026 7:40 am
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference - May 4th, 2026 2:15 pm
AnaptysBio (ANAB) Is Up 13.4% After Court Upholds Jemperli Royalty Rights In Tesaro Dispute - May 3rd, 2026 7:12 pm
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence - Apr 28th, 2026 5:12 pm
AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Apr 27th, 2026 8:00 am
AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains? - Apr 27th, 2026 6:18 am